Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulability

This publication has 11 references indexed in Scilit:

• Recombinant human erythropoietin shortens the uraemic bleeding time without causing intravascular haemostatic activation
  Thrombosis Research, 1990
• Plasma and platelet von Willebrand factor defects in uremia
  The American Journal of Medicine, 1988
• Effect of Arterial Revascularization on Transcutaneous Oxygen Tension of the Ischemic Extremity
  Mayo Clinic Proceedings, 1988
• IMPROVEMENT IN THE HAEMOSTATIC DEFECT OF URAEMIA AFTER TREATMENT WITH RECOMBINANT HUMAN ERYTHROPOIETIN
  The Lancet, 1987
• Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells
  Biochemistry, 1987
• Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
  New England Journal of Medicine, 1987
• EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS
  The Lancet, 1986
• Regional cerebral blood flow in dialysis encephalopathy and primary degenerative dementia
  Kidney International, 1985
• Cerebral blood flow measurement in cerebrovascular occlusive diseases.
  Stroke, 1984
• Hemodynamics of Uremic Anemia
  Circulation, 1971